BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

229 related articles for article (PubMed ID: 31944395)

  • 21. LncRNA BC200 regulates the cell proliferation and cisplatin resistance in non-small cell lung cancer via PI3K/AKT pathway.
    Gao BB; Wang SX
    Eur Rev Med Pharmacol Sci; 2019 Feb; 23(3):1093-1101. PubMed ID: 30779077
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Circ-ITCH correlates with less advanced tumor features as well as prolonged survival, and it inhibits cells proliferation but promotes apoptosis in non-small cell lung cancer.
    Li Z; Guo X; Gao S
    Transl Cancer Res; 2019 Sep; 8(5):1672-1679. PubMed ID: 35116916
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Circular RNA circ_0020123 promotes non-small cell lung cancer progression by acting as a ceRNA for miR-488-3p to regulate ADAM9 expression.
    Wan J; Hao L; Zheng X; Li Z
    Biochem Biophys Res Commun; 2019 Jul; 515(2):303-309. PubMed ID: 31153639
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The diagnostic value of has_circ_0006423 in non-small cell lung cancer and its role as a tumor suppressor gene that sponges miR-492.
    Zhu L; Sun L; Xu G; Song J; Hu B; Fang Z; Dan Y; Li N; Shao G
    Sci Rep; 2022 Aug; 12(1):13722. PubMed ID: 35962012
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A-kinase-interacting protein 1 overexpression correlates with deteriorative tumor features and worse survival profiles, and promotes cell proliferation but represses apoptosis in non-small-cell lung cancer.
    Chen H; Yan S; Dong L; Li X
    J Clin Lab Anal; 2020 Feb; 34(2):e23061. PubMed ID: 31828834
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Circular RNA SMARCA5 suppressed non-small cell lung cancer progression by regulating miR-670-5p/RBM24 axis.
    Zhang D; Ma Y; Ma Z; Liu S; Sun L; Li J; Zhao F; Li Y; Zhang J; Li S; Jiang J
    Acta Biochim Biophys Sin (Shanghai); 2020 Oct; 52(10):1071-1080. PubMed ID: 33085761
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Circular RNA hsa_circ_0014130 Inhibits Apoptosis in Non-Small Cell Lung Cancer by Sponging miR-136-5p and Upregulating BCL2.
    Geng Y; Bao Y; Zhang W; Deng L; Su D; Zheng H
    Mol Cancer Res; 2020 May; 18(5):748-756. PubMed ID: 32060230
    [TBL] [Abstract][Full Text] [Related]  

  • 28. High circ-SEC31A expression predicts unfavorable prognoses in non-small cell lung cancer by regulating the miR-520a-5p/GOT-2 axis.
    Jin M; Shi C; Hua Q; Li T; Yang C; Wu Y; Zhao L; Yang H; Zhang J; Hu C; Huang G
    Aging (Albany NY); 2020 Jun; 12(11):10381-10397. PubMed ID: 32499446
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Circ_0000003 promotes the proliferation and metastasis of non-small cell lung cancer cells via miR-338-3p/insulin receptor substrate 2.
    Li S; Niu X; Li H; Liang Y; Sun Z; Yan Y
    Cell Cycle; 2019 Dec; 18(24):3525-3539. PubMed ID: 31736412
    [No Abstract]   [Full Text] [Related]  

  • 30. Correlation of integrin alpha 7 with clinicopathological characteristics and survival profiles, as well as its regulatory role in cell proliferation, apoptosis, and stemness in non-small-cell lung cancer.
    Xia D; Chen B; Yang X
    J Clin Lab Anal; 2019 Oct; 33(8):e22973. PubMed ID: 31418948
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Knockdown of circ-ABCB10 promotes sensitivity of lung cancer cells to cisplatin via miR-556-3p/AK4 axis.
    Wu Z; Gong Q; Yu Y; Zhu J; Li W
    BMC Pulm Med; 2020 Jan; 20(1):10. PubMed ID: 31931771
    [TBL] [Abstract][Full Text] [Related]  

  • 32. HSA_CIRC_0004050 on proliferation and apoptosis of A549 cells through ERK/JNK signaling pathway.
    Wang Y; Zang RK; Du YN
    J Biol Regul Homeost Agents; 2020; 34(6):2037-2047. PubMed ID: 33348975
    [TBL] [Abstract][Full Text] [Related]  

  • 33. hsa_circ_0062389 promotes the progression of non-small cell lung cancer by sponging miR-103a-3p to mediate CCNE1 expression.
    She Y; Han Y; Zhou G; Jia F; Yang T; Shen Z
    Cancer Genet; 2020 Feb; 241():12-19. PubMed ID: 31962276
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Circ-IGF1R inhibits cell invasion and migration in non-small cell lung cancer.
    Xu Z; Xiang W; Chen W; Sun Y; Qin F; Wei J; Yuan L; Zheng L; Li S
    Thorac Cancer; 2020 Apr; 11(4):875-887. PubMed ID: 32107851
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Circular RNA mitochondrial translation optimization 1 correlates with less lymph node metastasis, longer disease-free survival, and higher chemotherapy sensitivity in gastric cancer.
    Chang C; Zheng A; Wang P; Teng X
    J Clin Lab Anal; 2022 Jun; 36(6):e23918. PubMed ID: 35478417
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Circular RNA circ-FOXM1 facilitates cell progression as ceRNA to target PPDPF and MACC1 by sponging miR-1304-5p in non-small cell lung cancer.
    Liu G; Shi H; Deng L; Zheng H; Kong W; Wen X; Bi H
    Biochem Biophys Res Commun; 2019 May; 513(1):207-212. PubMed ID: 30954221
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Circ-MTO1 correlates with favorable prognosis and inhibits cell proliferation, invasion as well as miR-17-5p expression in prostate cancer.
    Hu Y; Guo B
    J Clin Lab Anal; 2020 Mar; 34(3):e23086. PubMed ID: 31713278
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Circular RNA circ_0026134 regulates non-small cell lung cancer cell proliferation and invasion via sponging miR-1256 and miR-1287.
    Chang H; Qu J; Wang J; Liang X; Sun W
    Biomed Pharmacother; 2019 Apr; 112():108743. PubMed ID: 30970529
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Circular RNA La-related RNA-binding protein 4 correlates with reduced tumor stage, as well as better prognosis, and promotes chemosensitivity to doxorubicin in breast cancer.
    Zhang X; Su X; Guo Z; Jiang X; Li X
    J Clin Lab Anal; 2020 Jul; 34(7):e23272. PubMed ID: 32187743
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Circular RNA ABCB10 correlates with advanced clinicopathological features and unfavorable survival, and promotes cell proliferation while reduces cell apoptosis in epithelial ovarian cancer.
    Chen Y; Ye X; Xia X; Lin X
    Cancer Biomark; 2019; 26(2):151-161. PubMed ID: 31381507
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.